Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Vytokine Therapeutics General Information
Vytokine Therapeutics develops innovative medicines using a proprietary platform to display functional cytokines aimed at treating cancer and infectious diseases. No published clinical results as of now.[2][3][7]
Contact Information
Website
Primary Industry
Biotech
Corporate Office
West Sacramento, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
No major pharmaceutical partnerships publicly disclosed as of current data. *Note*: Synthekine has Merck partnership but this does not apply to Vytokine Therapeutics.[6] *No evidence for academic collaborations or licensees in public sources.*
Vytokine Therapeutics Funding
No funding data available
To view Vytokine Therapeutics's complete valuation and funding history, request access »
Gosset